News

UCSF First in State to Provide FDA-Approved CAR-T for Pediatric Cancer Patients

UCSF Benioff Children’s Hospital San Francisco has been certified as the first medical center in California to provide CAR-T therapy for children and young adults with acute lymphoblastic leukemia (ALL), who have failed standard treatment. The first pediatric patient at UCSF Benioff Children’s

University of California Cancer Consortium Takes on California's $14 Billion Killer

The University of California’s five academic cancer centers, home to some of the world’s leading scientists and physicians, have formed a consortium to better address California’s most pressing cancer-related problems and opportunities, UC President Janet Napolitano and Dr. John Stobo, executive

Breast Cancer Patients Who Freeze Their Eggs See No Delay for Chemotherapy

Women who receive a breast cancer diagnosis while they are still young enough to bear children can take time to freeze their eggs and embryos without fear of delaying their cancer treatment, according to research by UC San Francisco scientists who have helped develop a faster fertility preservation

From Threat to Opportunity: Study Shows Cigarette Makers Shifted Stance on Nicotine Patches, Gum

The use of nicotine patches, gum, lozenges, inhalers or nasal sprays – together called “nicotine replacement therapy,” or NRT – came into play in 1984 as prescription medicine, which when combined with counseling, helped smokers quit. But in 1996, at the urging of pharmaceutical companies, the U.S

Analysis Shows UCSF Cancer Research Ranks Among the World's Most Impactful

From patent filings for new cancer therapies, to articles and book chapters on the latest advances in understanding, diagnosing and treating cancer, University of California San Francisco's Helen Diller Family Comprehensive Cancer Center is consistently among the world's top five institutions

UCSF Medical Center Ranks as Best Hospital in California

UCSF Medical Center has been named among the nation’s premier medical institutions for the 17th consecutive year, ranking as the fifth best hospital in the country and the top-ranked hospital in California, in U.S. News & World Report’s 2017-2018 Best Hospitals survey. UCSF received elite Honor Roll

Immune-Cell Numbers Predict Response to Combination Immunotherapy in Melanoma

Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco researchers joined by physicians from UCSF Health. The findings